Journal
CLINICAL INFECTIOUS DISEASES
Volume 34, Issue 3, Pages 346-353Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/338260
Keywords
-
Categories
Funding
- NIA NIH HHS [AG00971, AG00755] Funding Source: Medline
Ask authors/readers for more resources
A total of 271 patients were prospectively followed up to determine whether patients whose hospital stay is complicated by diarrhea due to Clostridium difficile experience differences in cost and length of stay and survival rates when compared with patients whose stay is not complicated by C. difficile-associated diarrhea. Forty patients (15%) developed nosocomial C. difficile-associated diarrhea. These patients incurred adjusted hospital costs of $3669-that is, 54% (95% confidence interval [CI], 17%-103%)-higher than patients whose course was not complicated by C. difficile-associated diarrhea. The extra length of stay attributable to C. difficile-associated diarrhea was 3.6 days (95% CI, 1.5-6.2). C. difficile-associated diarrhea was not associated with excess 3-month or 1-year mortality after adjustment for age, comorbidity, and disease severity. On the basis of the findings of this study, a conservative estimate of the cost of this disease in the United States exceeds $1.1 billion per year.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available